Publications
Recent (2022) Selected Publications
- Cao W, Rocha H, Mohan R, et al. Reflections on beam configuration optimization for intensity-modulated proton therapy. Phys Med Biol 2022;67. https://www.ncbi.nlm.nih.gov/pubmed/35561700
- Ebrahimi S, Lim G, Hobbs BP, et al. A hybrid deep learning model for forecasting lymphocyte depletion during radiation therapy. Med Phys 2022. https://www.ncbi.nlm.nih.gov/pubmed/35229311
- Engeseth GM, Hysing LB, Yepes P, et al. Impact of rbe variations on risk estimates of temporal lobe necrosis in patients treated with intensity-modulated proton therapy for head and neck cancer. Acta Oncol 2022;61:215-222. https://www.ncbi.nlm.nih.gov/pubmed/34534047
- Mairani A, Mein S, Blakely EA, et al. Roadmap: Helium ion therapy. Phys Med Biol 2022. https://www.ncbi.nlm.nih.gov/pubmed/35395649
- Meyer HJ, Titt U, Mohan R. Technical note: Monte carlo study of the mechanism of proton-boron fusion therapy. Med Phys 2022;49:579-582. https://www.ncbi.nlm.nih.gov/pubmed/34822721
- Monti S, Xu T, Liao Z, et al. On the interplay between dosiomics and genomics in radiation-induced lymphopenia of lung cancer patients. Radiother Oncol 2022;167:219-225. https://www.ncbi.nlm.nih.gov/pubmed/34979216
- Monti S, Xu T, Mohan R, et al. Radiation-induced esophagitis in non-small-cell lung cancer patients: Voxel-based analysis and ntcp modeling. Cancers 2022;14. https://www.ncbi.nlm.nih.gov/pubmed/35406605
- Titt U, Yang M, Wang X, et al. Design and validation of a synchrotron proton beam line for flash radiotherapy preclinical research experiments. Med Phys 2022;49:497-509. https://www.ncbi.nlm.nih.gov/pubmed/34800037
- Vassiliev ON, Peterson CB, Chang JY, et al. Monte carlo evaluation of target dose coverage in lung stereotactic body radiation therapy with flattening filter-free beams. J Radiother Pract 2022;21:81-87. https://www.ncbi.nlm.nih.gov/pubmed/35401050
- Ajdari A, Liao Z, Mohan R, et al. Personalized mid-course fdg-pet based adaptive treatment planning for non-small cell lung cancer using machine learning and optimization. Phys Med Biol 2022;67. https://www.ncbi.nlm.nih.gov/pubmed/35947984
- Ebrahimi S, Lim G, Hobbs BP, et al. A hybrid deep learning model for forecasting lymphocyte depletion during radiation therapy. Med Phys 2022;49:3507-3522. https://www.ncbi.nlm.nih.gov/pubmed/35229311
- Ellsworth SG, Yalamanchali A, Lautenschlaeger T, et al. Lymphocyte depletion rate as a biomarker of radiation dose to circulating lymphocytes during fractionated partial-body radiation therapy. Adv Radiat Oncol 2022;7:100959. https://www.ncbi.nlm.nih.gov/pubmed/35928987
- He Y, Anderson BM, Cazoulat G, et al. Optimization of mesh generation for geometric accuracy, robustness, and efficiency of biomechanical-model-based deformable image registration. Med Phys 2022. https://www.ncbi.nlm.nih.gov/pubmed/35978544
- Jing W, Xu T, Wu L, et al. Severe radiation-induced lymphopenia attenuates the benefit of durvalumab after concurrent chemoradiotherapy for NSCLC. JTO Clin Res Rep 2022;3:100391. https://www.ncbi.nlm.nih.gov/pubmed/36089921
- Mairani A, Mein S, Blakely E, et al. Roadmap: Helium ion therapy. Phys Med Biol 2022;67. https://www.ncbi.nlm.nih.gov/pubmed/35395649
- Mohan R. Intensity-modulated radiation therapy. Med Phys 2022. https://www.ncbi.nlm.nih.gov/pubmed/36377546
- Mohan R. A review of proton therapy - current status and future directions. Precis Radiat Oncol 2022;6:164-176. https://www.ncbi.nlm.nih.gov/pubmed/36160180
- Pompos A, Foote RL, Koong AC, et al. National effort to re-establish heavy ion cancer therapy in the united states. Frontiers in oncology 2022;12:880712. https://www.ncbi.nlm.nih.gov/pubmed/35774126
- Wang Q, Titt U, Mohan R, et al. Optimization of flash proton beams using a track-repeating algorithm. Med Phys 2022;49:6684-6698. https://www.ncbi.nlm.nih.gov/pubmed/35900902
- Yang M, Wang X, Guan F, et al. Adaptation and dosimetric commissioning of a synchrotron-based proton beamline for flash experiments. Phys Med Biol 2022;67. https://www.ncbi.nlm.nih.gov/pubmed/35853442
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.